Cohort profile - the Renal cell cancer: Lifestyle, prognosis and quality of life (ReLife) study in the Netherlands.

Jake S F MauritsJ P Michiel SedelaarKatja K H AbenEllen Kampmannull nullLambertus A L M KiemeneyAlina Vrieling

Published in: BMJ open (2023)

Data collection at 2 years after treatment is expected to be finalised in June 2023 and longitudinal clinical data will continue to be collected. Results of studies based on this cohort are important to develop personalised evidence-based lifestyle advice for patients with localised RCC to enable them to get more control over their disease course.

Keyphrases

electronic health record
metabolic syndrome
cardiovascular disease
physical activity
big data
papillary thyroid
weight loss
single cell
cell therapy
cross sectional
squamous cell
data analysis
type diabetes
artificial intelligence
renal cell carcinoma
squamous cell carcinoma
bone marrow